Savikalpa Sciences

Savikalpa Sciences is an Indian phytopharmaceutical and biotechnology company focused on developing research-driven, cannabis-derived medicines and polyherbal formulations. Founded in 2020 and headquartered in New Delhi, the company aims to bridge the gap between traditional Ayurvedic knowledge and modern clinical science. Savikalpa's product portfolio includes clinically-backed topical and oral cannabinoid formulations, marketed under brands like Shunyata and Svaha, targeting indications such as chronic pain, migraines, arthritis, anxiety, and sleep disorders. The company collaborates with leading research organizations, including the Dabur Research Foundation, to conduct rigorous preclinical and clinical studies to validate the safety and efficacy of its cannabinoid-based therapies.